Surveillance report describes 2021 vaccination coverage among US adolescents aged 13-17

This observational surveillance report described national vaccination coverage among adolescents aged 13-17 years in the United States for 2021. The report did not specify which vaccines were included, provide a sample size, or identify a comparator group. The main finding was that vaccination coverage was described, but no specific coverage percentages, absolute numbers, effect sizes, or statistical measures were reported.

No safety or tolerability data were reported in this surveillance report. The report did not document adverse events, serious adverse events, or discontinuations related to vaccination.

Key limitations include the purely descriptive nature of the data, the absence of specific coverage rates or trends, and the lack of comparative analysis. Funding sources and potential conflicts of interest were not reported. The practice relevance is limited to providing a general snapshot of 2021 adolescent vaccination coverage without detailed metrics for clinical decision-making.